Cell & Gene Therapy Insights is an online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects of the cell and gene therapy field.
Cell & Gene Therapy Insights addresses the important challenges and advances in advanced therapies, publishing original research, reviews, commentary articles, clinical trial reports, and much more. You can find more information about our aims and scope here.
Sign-up for free for unlimited access to all of our articles, webinars, podcasts, news, interviews, and more.
December 2024
Upcoming webinars
Case study: developing an ex vivo gene-modified hematopoietic stem cell treatment for a rare monogenic disease in a novel mouse model
Rafael A. Badell-Grau
29 January
in 15
Days
Big pharma case study: alpha testing of a generic anti-AAV kit and comparison to in-house methods
Kira Hedström, Eva-Maria Thüring
30 January
in 16
Days
Advancing AAV manufacturing: strategic insights and cost-effective solutions for the future of gene therapies
M DiBiasio-White, Y Cai, R Pach
6 February
in 23
Days
Producing engineered extracellular vesicles with a platform approach
Vijetha Bhat
13 February
in 30
Days
Closed and automated CAR-T production: a fast, simple workflow for high-dose, high-quality cells
Wenyan Leong, Louise Tan
19 February
in 35
Days
AAV capsid analysis and quantification with chromatography and ultracentrifugation-based techniques
Andreja Livk, Sebastijan Peljhan
27 February
in 44
Days
Latest Articles
What removing the DNA synthesis bottleneck means for the future of drug discovery and development
Elizabeth Wood
14 January
Connecting innovations to great gains for the ultimate stakeholder: the patient
Michelle Berg
13 January
Personalization in advanced cellular ImmunoTherapeutics: activities in Ireland
Athanasios Mantalaris, Nicki Panoskaltsis, Fiona Killard
13 January
Corrigendum to: Interpreting the new FDA draft potency guidance: an RNA cell therapy perspective
Damian Marshall, Kayleigh Thirlwell
19 December 2024
Corrigendum to: Generation of novel AAV serotypes with enhanced infectivity, specificity, and lower toxicity via AAV capsid engineering platform
Y Bu, Y Pan, Y Zhong et al.
19 December 2024
Implementing platform-based technologies to scale viral vector manufacturing consistently and efficiently
Xueyuan Liu
19 December 2024
Manufacturing of CD19 CAR-T cells: INFOGRAPHIC
19 December 2024
‘Winning’ target product profiles for CAR-T cell therapies in oncology: critical success factors for commercially viable therapies
Clare Hague, Louise Street-Docherty, Frances Pearson
19 December 2024
Novel isolation platform with active-release technology for scalable cell therapy manufacturing
Ingrid Nyhus Moen
18 December 2024
Channel content
Personalization in advanced cellular ImmunoTherapeutics: activities in Ireland
Athanasios Mantalaris, Nicki Panoskaltsis, Fiona Killard
13 January
Implementing platform-based technologies to scale viral vector manufacturing consistently and efficiently
Xueyuan Liu
19 December 2024
Manufacturing of CD19 CAR-T cells: INFOGRAPHIC
19 December 2024
Implementing platform-based technologies to scale viral vector manufacturing consistently and efficiently
Xueyuan Liu
19 December 2024
Demystifying AAV affinity capture: mapping AAV affinity ligand footprints with cryo-electron microscopy
Nathaniel Clark
13 December 2024
Navigating the complexities of AAV and lentiviral vector characterization
Susumu Uchiyama
12 December 2024
Implementing platform-based technologies to scale viral vector manufacturing consistently and efficiently
Xueyuan Liu
19 December 2024
Navigating the complexities of AAV and lentiviral vector characterization
Susumu Uchiyama
12 December 2024
Balancing precision and efficiency in cell therapy assays: low volume sampling for mycoplasma detection
Sharon Rouw
10 December 2024
Shifting to non-viral in vivo therapies to enhance global patient access to genetic medicines
Hari Pujar
26 September 2024
Navigating the European landscape of advanced therapy funding and commercialization
Dmitry A Kuzmin
2 September 2024
Driving digital innovation for supply chain orchestration in cell and gene therapy
Christian Fuchs
27 August 2024
‘Winning’ target product profiles for CAR-T cell therapies in oncology: critical success factors for commercially viable therapies
Clare Hague, Louise Street-Docherty, Frances Pearson
19 December 2024
Pioneering quality control in biomanufacturing of cell and gene therapies
Dhruv Sareen, Jonathan Rodriguez
5 December 2024
Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance
Edward Grimley, Leanne Kodsmann
4 December 2024
Personalization in advanced cellular ImmunoTherapeutics: activities in Ireland
Athanasios Mantalaris, Nicki Panoskaltsis, Fiona Killard
13 January
Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance
Edward Grimley, Leanne Kodsmann
4 December 2024
Operations strategy for a scalable CGT supply chain: key CXO insights
Shesh Sharma, Tim Sirichoke, Edward Ballesteros
2 December 2024
Looking to a future of multiplex cell engineering
Marco Alessandrini
11 January 2024
Exploring the burgeoning role of non-viral approaches in the delivery of nucleic acids
Zhenghong Gao
5 January 2024
Biological & operational considerations for iPSC-derived cell production
A Mogen, A Fernandez-Perez, J Wang et al.
20 December 2023
